Pharmacological strategies for self- management of asthma exacerbations REVIEW
... ABSTRACT: Written action plans are effective within asthma self-management, but there are few guidelines about the specific medication adjustments which can be recommended for selftreatment of exacerbations. This review examines pharmacological strategies for self-management of asthma exacerbations ...
... ABSTRACT: Written action plans are effective within asthma self-management, but there are few guidelines about the specific medication adjustments which can be recommended for selftreatment of exacerbations. This review examines pharmacological strategies for self-management of asthma exacerbations ...
Chapter 22 to 33
... disease, tooth decay and tooth loss, and other diseases and disorders that affect the oral cavity. Dental plaque is the biofilm formed on tooth surfaces by aggregation of microorganisms. It is a complex, metabolically interconnected bacterial ecosystem. It can lead to development of various oral dis ...
... disease, tooth decay and tooth loss, and other diseases and disorders that affect the oral cavity. Dental plaque is the biofilm formed on tooth surfaces by aggregation of microorganisms. It is a complex, metabolically interconnected bacterial ecosystem. It can lead to development of various oral dis ...
Treatment of Patients With Schizophrenia Second Edition
... the basis of all clinical data available for an individual patient and are subject to change as scientific knowledge and technology advance and practice patterns evolve. These parameters of practice should be considered guidelines only. Adherence to them will not ensure a successful outcome for ever ...
... the basis of all clinical data available for an individual patient and are subject to change as scientific knowledge and technology advance and practice patterns evolve. These parameters of practice should be considered guidelines only. Adherence to them will not ensure a successful outcome for ever ...
Attached file 3a 14-14215-Woodcock-cgs-jmd
... dramatic responses to trials of acid suppression therapy for two months, even in the absence of GERD symptoms. Our rationale is that the treatment is inexpensive, has few side effects, and if it is successful long term use is not likely to yield any harm. If there is no identifiable response, we dis ...
... dramatic responses to trials of acid suppression therapy for two months, even in the absence of GERD symptoms. Our rationale is that the treatment is inexpensive, has few side effects, and if it is successful long term use is not likely to yield any harm. If there is no identifiable response, we dis ...
monoclonal antibodies to choline acetyltransferase: production
... Each of the monoclonal antibodies exhibits one of three general patterns of cross-species reactions; one pattern shows reactivity limited mainly to bovine ChAT, a second pattern shows reactivity only to ChAT from higher mammals including humans, and the third pattern shows reactivity to ChAT from al ...
... Each of the monoclonal antibodies exhibits one of three general patterns of cross-species reactions; one pattern shows reactivity limited mainly to bovine ChAT, a second pattern shows reactivity only to ChAT from higher mammals including humans, and the third pattern shows reactivity to ChAT from al ...
p. S25 - Viktor`s Notes for the Neurosurgery Resident
... AURA - focal neurological symptoms (positive or negative phenomena) that precede or accompany attack. aura symptoms develop over 5-20 minutes and last < 60 minutes (aura > 1 hour - complicated migraine). headache, when present, occurs within 60 minutes of end of aura; most patients do not feel w ...
... AURA - focal neurological symptoms (positive or negative phenomena) that precede or accompany attack. aura symptoms develop over 5-20 minutes and last < 60 minutes (aura > 1 hour - complicated migraine). headache, when present, occurs within 60 minutes of end of aura; most patients do not feel w ...
Brace treatment for Patients with Scheuermann Disease – A review
... The common indications for treatment in Scheuermann kyphosis are related to pain, progression of deformity and appearance. Pain is difficult to measure because of its subjective and temporal nature [8]. Most of the literature on Scheuermann kyphosis states that pain is either present or absent, and ...
... The common indications for treatment in Scheuermann kyphosis are related to pain, progression of deformity and appearance. Pain is difficult to measure because of its subjective and temporal nature [8]. Most of the literature on Scheuermann kyphosis states that pain is either present or absent, and ...
ERS-ATS COPD Guidelines
... LA-BD: long-acting bronchodilator; ICS: inhaled corticosteroid. Assess effectiveness by treatment response criteria. If forced expiratory volume <50% predicted and exacerbations of COPD requiring a course of oral corticosteroid or antibiotic occurred at least once within the last year, consider addi ...
... LA-BD: long-acting bronchodilator; ICS: inhaled corticosteroid. Assess effectiveness by treatment response criteria. If forced expiratory volume <50% predicted and exacerbations of COPD requiring a course of oral corticosteroid or antibiotic occurred at least once within the last year, consider addi ...
Contents
... Achalasia is the classic primary esophageal dysmotility. It is characterized by incomplete relaxation of the LES. It often is associated with hypertensive resting LES pressure and aperistalsis of the esophageal body. The etiology of achalasia is unknown, but it has been associated with loss of the g ...
... Achalasia is the classic primary esophageal dysmotility. It is characterized by incomplete relaxation of the LES. It often is associated with hypertensive resting LES pressure and aperistalsis of the esophageal body. The etiology of achalasia is unknown, but it has been associated with loss of the g ...
Stinging Nettle: the Bad, the Good, the Unknown
... that may actually induce allergic rhinitis, may not be founded given the lack of cross-reactivity between protein pollens of representatives of these two species.28 Experts have expressed concern for the use of stinging nettle extracts for allergic rhinitis given their potential for side effects and ...
... that may actually induce allergic rhinitis, may not be founded given the lack of cross-reactivity between protein pollens of representatives of these two species.28 Experts have expressed concern for the use of stinging nettle extracts for allergic rhinitis given their potential for side effects and ...
Final Protocol - Word 1986 KB - Medical Services Advisory Committee
... eligible for re-treatment with ocriplasmin and as such, monitoring of patients for subsequent treatment will not be required. Patients who do not respond to treatment with ocriplasmin are to be managed by standard clinical management that includes either watchful waiting or vitrectomy. The benefit o ...
... eligible for re-treatment with ocriplasmin and as such, monitoring of patients for subsequent treatment will not be required. Patients who do not respond to treatment with ocriplasmin are to be managed by standard clinical management that includes either watchful waiting or vitrectomy. The benefit o ...
Pharyngitis Treatment - Michele Jones`Professional Portfolio
... pharyngitis (Cingi et al., 2011). Other interventions that are effective at relieving pharyngitis include analgesic medications (Fashner et al., 2012). Cingi et al (2011) researched the throat spray chlorhexidine gluconate and benzydamine HCl and showed it to be effective at reducing pain and inflam ...
... pharyngitis (Cingi et al., 2011). Other interventions that are effective at relieving pharyngitis include analgesic medications (Fashner et al., 2012). Cingi et al (2011) researched the throat spray chlorhexidine gluconate and benzydamine HCl and showed it to be effective at reducing pain and inflam ...
Refill Adherence to Long-Term Drug Treatment with a
... the population independent of age, gender, race, education or socioeconomic status [4]. Furthermore, non-adherence is observed in all types of diseases, i.e. acute and chronic, serious and non-serious and in relation to both symptom-alleviating and other drug treatment [1]. The fact that many patien ...
... the population independent of age, gender, race, education or socioeconomic status [4]. Furthermore, non-adherence is observed in all types of diseases, i.e. acute and chronic, serious and non-serious and in relation to both symptom-alleviating and other drug treatment [1]. The fact that many patien ...
Key points - ERS e-Learning Resources
... limitation and a large response to bronchodilators. In these patients, the forced expiratory volume in one second (FEV1) does not return to normal and frequently worsens over time. There is a great need to design studies aimed at determining the prevalence, natural history, clinical course and thera ...
... limitation and a large response to bronchodilators. In these patients, the forced expiratory volume in one second (FEV1) does not return to normal and frequently worsens over time. There is a great need to design studies aimed at determining the prevalence, natural history, clinical course and thera ...
Report - Institute for Clinical and Economic Review
... For patients unable to take statins, or for patients taking statins but not meeting their LDL-C goals, additional drugs are available, with ezetimibe (Zetia®) being the most relevant for this review. Ezetimibe inhibits the absorption of cholesterol in the intestines. Meta-analyses of randomized tria ...
... For patients unable to take statins, or for patients taking statins but not meeting their LDL-C goals, additional drugs are available, with ezetimibe (Zetia®) being the most relevant for this review. Ezetimibe inhibits the absorption of cholesterol in the intestines. Meta-analyses of randomized tria ...
Malawi Government
... thereby promoting more consistent therapeutics and rational use of the medicines and medical supplies needed to provide health services. This further facilitates the estimation, procurement and supply of medicines and supplies. For a given diagnosis, many patients may not be prescribed or subsequent ...
... thereby promoting more consistent therapeutics and rational use of the medicines and medical supplies needed to provide health services. This further facilitates the estimation, procurement and supply of medicines and supplies. For a given diagnosis, many patients may not be prescribed or subsequent ...
COPD - HSE
... capacity to influence the natural history of the disease.1, 4, 9, 10 All patients should be actively encouraged to quit smoking and appropriate support should be provided. For more information on smoking cessation support services, visit www.quit.ie. 4.2 Inhaled therapies for COPD None of the existi ...
... capacity to influence the natural history of the disease.1, 4, 9, 10 All patients should be actively encouraged to quit smoking and appropriate support should be provided. For more information on smoking cessation support services, visit www.quit.ie. 4.2 Inhaled therapies for COPD None of the existi ...
Nursing Management
... Nearly half of the users of these therapies do not consult an alternative and complementary practitioner or disclose such use to their traditional health care provider. ...
... Nearly half of the users of these therapies do not consult an alternative and complementary practitioner or disclose such use to their traditional health care provider. ...
Team players against headache: multidisciplinary treatment of
... There is strong evidence that various types of relaxation training (e.g. thermal/electromyography (EMG) biofeedback) may be an effective treatment for the prevention of migraine [17, 20]. There is weaker evidence that relaxation training may be combined with preventive drug therapy (i.e. propranolol ...
... There is strong evidence that various types of relaxation training (e.g. thermal/electromyography (EMG) biofeedback) may be an effective treatment for the prevention of migraine [17, 20]. There is weaker evidence that relaxation training may be combined with preventive drug therapy (i.e. propranolol ...
RoActemra : EPAR - EMA
... agents including RoActemra (see section 4.8, undesirable effects). RoActemra treatment must not be initiated in patients with active infections (see section 4.3). Administration of RoActemra should be interrupted if a patient develops a serious infection until the infection is controlled (see sectio ...
... agents including RoActemra (see section 4.8, undesirable effects). RoActemra treatment must not be initiated in patients with active infections (see section 4.3). Administration of RoActemra should be interrupted if a patient develops a serious infection until the infection is controlled (see sectio ...
Reasons for Decision
... In his written submission Dr Traill stated that he had been denied natural justice because the Notice had been amended at the end of the five day hearing of evidence and oral submissions and after witnesses had provided testimony and been cross examined. Dr Traill said that he had no legal advice ab ...
... In his written submission Dr Traill stated that he had been denied natural justice because the Notice had been amended at the end of the five day hearing of evidence and oral submissions and after witnesses had provided testimony and been cross examined. Dr Traill said that he had no legal advice ab ...
Treatment of Patients With Acute Stress Disorder and Posttraumatic Stress Disorder
... persons with early symptoms and identify those at risk for the development of PTSD. Research and clinical experience show that those with high levels of symptoms early on, including those with ASD, are at risk of subsequent PTSD; however, some patients with ASD do not develop PTSD, and a proportion ...
... persons with early symptoms and identify those at risk for the development of PTSD. Research and clinical experience show that those with high levels of symptoms early on, including those with ASD, are at risk of subsequent PTSD; however, some patients with ASD do not develop PTSD, and a proportion ...
A History of Streptokinase Use in Acute Myocardial Infarction
... substance was called fibrinolysin (later named streptokinase). Because clot lysed faster in fibrinogen preparations than in plasma, Tillett’s team also predicted the presence of a plasma fibrinolytic inhibitor. In 1934, Tillett and co-authors21 stated that “the plasma-clot from the blood of patients ...
... substance was called fibrinolysin (later named streptokinase). Because clot lysed faster in fibrinogen preparations than in plasma, Tillett’s team also predicted the presence of a plasma fibrinolytic inhibitor. In 1934, Tillett and co-authors21 stated that “the plasma-clot from the blood of patients ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.